[
    [
        {
            "time": "",
            "original_text": "白酒、医药多股涨停：财富制造机重启？这些个股已处加仓临界点？",
            "features": {
                "keywords": [
                    "白酒",
                    "医药",
                    "涨停",
                    "财富制造",
                    "加仓"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白酒、医药多股涨停：财富制造机重启？这些个股已处加仓临界点？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03",
            "original_text": "西南证券 - 医药行业2021年3月投资月报：核心资产大跌之后性价比凸显，建议关注PEG投资机会【行业研究】",
            "features": {
                "keywords": [
                    "医药",
                    "核心资产",
                    "大跌",
                    "性价比",
                    "PEG",
                    "投资机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "西南证券 - 医药行业2021年3月投资月报：核心资产大跌之后性价比凸显，建议关注PEG投资机会【行业研究】",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "渤海证券 - 医药行业周报：中短期关注业绩同比增长的细分领域优质企业【行业研究】",
            "features": {
                "keywords": [
                    "医药",
                    "中短期",
                    "业绩",
                    "同比增长",
                    "细分领域",
                    "优质企业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渤海证券 - 医药行业周报：中短期关注业绩同比增长的细分领域优质企业【行业研究】",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-03",
            "original_text": "2021年医药行业3月策略报告：三个策略应对医药板块的波动",
            "features": {
                "keywords": [
                    "医药",
                    "策略",
                    "波动"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021年医药行业3月策略报告：三个策略应对医药板块的波动",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "【医药】中短期关注2020Q1业绩高增长的细分领域优质企业——医药行业周报——中性",
            "features": {
                "keywords": [
                    "医药",
                    "中短期",
                    "2020Q1",
                    "业绩",
                    "高增长",
                    "细分领域",
                    "优质企业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】中短期关注2020Q1业绩高增长的细分领域优质企业——医药行业周报——中性",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]